Guardian Pharmacy Services, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Guardian Pharmacy Services, Inc. (GRDN) on March 24, 2025. The filing addresses Item 5.02 regarding the establishment of performance criteria for the 2025 Annual Incentive Program for executive officers.
Key Financial Metrics
The filing does not provide specific financial results such as revenue, profit, cash flow, margins, debt, or liquidity figures for the current or prior periods. The document focuses exclusively on executive compensation structure.
Material Changes and Compensation Structure
On March 24, 2025, the Compensation Committee established the 2025 Annual Incentive Program under the 2024 Equity and Incentive Compensation Plan. The program utilizes three weighted performance metrics:
- 2025 Company Revenue: Weighted at 20%.
- 2025 Company Adjusted EBITDA: Weighted at 60%.
- Geographic Expansion: Weighted at 20%.
Payouts are structured as follows: 75% of the target award for threshold performance, 100% for target performance, and 125% for maximum performance.
Executive Officer Award Opportunities
| Executive Officer | Threshold Payout | Target Payout | Maximum Payout |
|---|---|---|---|
| Fred Burke (President & CEO) | $208,575 | $278,100 | $347,625 |
| David Morris (EVP & CFO) | $185,400 | $247,200 | $309,000 |
| Kendall Forbes (EVP, Sales & Operations) | $185,400 | $247,200 | $309,000 |
Guidance, Outlook, and Risks
The filing does not contain forward-looking financial guidance, management commentary on market conditions, or specific risk factors beyond the inherent performance risks of the incentive plan. The filing does not disclose the specific numerical targets for revenue, Adjusted EBITDA, or geographic expansion required to achieve the payout tiers.
Key Facts for Investor Verification
- Verify the specific numerical targets for 2025 Revenue, Adjusted EBITDA, and geographic expansion in subsequent filings or proxy statements, as they are not disclosed in this 8-K.
- Confirm the total potential cash outlay for executive incentives, which could reach approximately $965,625 if all executives achieve maximum performance.
- Note that Adjusted EBITDA is the primary driver (60%) of executive compensation for the 2025 fiscal year.